A startup that’s developing a blood test to diagnose the cause of stroke is planning a clinical study that could pave the way to commercial sales of the test.Cincinnati-based IschemiaCare plans to begin the study in the second half of this year, and the young company has attracted some big-name partners to help it get [...]

A startup that’s hoping to be the first to commercialize a blood test that can diagnose the cause of stroke has received a state loan for nearly $1 million.The $943,000 in financing for Cincinnati-area IschemiaCare comes through the Innovation Ohio Loan Fund program, which is aimed at helping companies in the state develop “next-generation” products.IschemiaCare‘s [...]

A company that’s hoping to be the first to commercialize a blood test that can diagnose the cause of stroke has closed $800,000 of an anticipated $1.1 million series B round of investment.Cincinnati-area-based IschemiaCare expects to close on the full $1.1 million by the end of the year. The funding will enable the company to [...]